Skip to Content

M CL3 (Carbidopa and Levodopa 25 mg / 250 mg)

Pill with imprint M CL3 is Blue, Round and has been identified as Carbidopa and Levodopa 25 mg / 250 mg. It is supplied by Mylan Pharmaceuticals Inc..

Carbidopa/levodopa is used in the treatment of parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M CL3

Carbidopa and Levodopa

Imprint
M CL3
Strength
25 mg / 250 mg
Color
Blue
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-1133
Inactive Ingredients
crospovidone, hydroxypropyl cellulose (type h), magnesium stearate, microcrystalline cellulose, corn starch, FD&C Blue No. 2

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "M CL3"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.